Estrogen receptor β agonists affect growth and gene expression of human breast cancer cell lines

Steroids

Volumn 78, Issue 2, 2013, Pages 195-202

  Lattrich, Claus ^a   Stegerer, Anette ^a   Häring, Julia ^a   Schüler, Susanne ^a   Ortmann, Olaf ^a   Treeck, Oliver ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Agonist; Breast cancer; Estrogen receptor ; Proliferation

Indexed keywords

3BETA ADIOL; ANTINEOPLASTIC AGENT; CYCLIN A2; CYCLIN B1; CYCLIN D1; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; HORMONE DERIVATIVE; KI 67 ANTIGEN; LIQUIRITIGENIN; PROGESTERONE RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER GROWTH; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; DRUG MEGADOSE; ENZYME ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; TREATMENT DURATION;

ALTERNATIVE SPLICING; ANDROSTANE-3,17-DIOL; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN B1; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTROGEN RECEPTOR BETA; FEMALE; FLAVANONES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; TIME FACTORS;

EID: 84871460759     PISSN: 0039128X     EISSN: 18785867     Source Type: Journal    
DOI: 10.1016/j.steroids.2012.10.014     Document Type: Article

References (32)

1. S.M. Cowley, S. Hoare, S. Mosselman, and M.G. Parker Estrogen receptors alpha and beta form heterodimers on DNA J Biol Chem 272 1997 19858 19862
2. O. Treeck, C. Lattrich, A. Springwald, and O. Ortmann Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cells Breast Cancer Res Treat 120 2010 557 565
3. V. Speirs, P.J. Carder, S. Lane, D. Dodwell, M.R. Lansdown, and A.M. Hanby Oestrogen receptor beta: what it means for patients with breast cancer Lancet Oncol 5 2004 174 181
4. M. Younes, and N. Honma Estrogen receptor beta Arch Pathol Lab Med 135 2011 63 66
5. Y.K. Leung, P. Mak, S. Hassan, and S.M. Ho Estrogen receptor (ER)-beta isoforms: a key to understanding ER-beta signaling Proc Natl Acad Sci USA 103 2006 13162 13167
6. O. Treeck, I. Juhasz-Boess, C. Lattrich, F. Horn, R. Goerse, and O. Ortmann Effects of exon-deleted estrogen receptor beta transcript variants on growth, apoptosis and gene expression of human breast cancer cell lines Breast Cancer Res Treat 110 2008 507 520
7. S. Paruthiyil, H. Parmar, V. Kerekatte, G.R. Cunha, G.L. Firestone, and D.C. Leitman Estrogen receptor beta inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest Cancer Res 64 2004 423 428
8. N. Honma, R. Horii, T. Iwase, S. Saji, M. Younes, and K. Takubo Clinical importance of estrogen receptor-beta evaluation in breast cancer patients treated with adjuvant tamoxifen therapy J. Clin. Oncol.: Offic. J. Am. Soc. Clin. Oncol. 26 2008 3727 3734
9. S. Ogawa, S. Inoue, T. Watanabe, A. Orimo, T. Hosoi, and Y. Ouchi Molecular cloning and characterization of human estrogen receptor betacx: a potential inhibitor ofestrogen action in human Nucleic Acids Res. 26 1998 3505 3512
10. H. Sugiura, T. Toyama, Y. Hara, Z. Zhang, S. Kobayashi, and Y. Fujii Expression of estrogen receptor beta wild-type and its variant ERbetacx/beta2 is correlated with better prognosis in breast cancer Jpn J Clin Oncol 37 2007 820 828
11. C. Zhao, J. Matthews, M. Tujague, J. Wan, A. Strom, and G. Toresson Estrogen receptor beta2 negatively regulates the transactivation of estrogen receptor alpha in human breast cancer cells Cancer Res 67 2007 3955 3962
12. I. Girault, C. Andrieu, S. Tozlu, F. Spyratos, I. Bieche, and R. Lidereau Altered expression pattern of alternatively spliced estrogen receptor beta transcripts in breast carcinoma Cancer Lett 215 2004 101 112
13. J.E. Mersereau, N. Levy, R.E. Staub, S. Baggett, T. Zogovic, and S. Chow Liquiritigenin is a plant-derived highly selective estrogen receptor beta agonist Mol Cell Endocrinol 283 2008 49 57
14. V. Guerini, D. Sau, E. Scaccianoce, P. Rusmini, P. Ciana, and A. Maggi The androgen derivative 5alpha-androstane-3beta,17beta-diol inhibits prostate cancer cell migration through activation of the estrogen receptor beta subtype Cancer Res 65 2005 5445 5453
15. Z. Weihua, R. Lathe, M. Warner, and J.A. Gustafsson An endocrine pathway in the prostate, ERbeta, AR, 5alpha-androstane-3beta,17beta-diol, and CYP7B1, regulates prostate growth Proc Natl Acad Sci USA 99 2002 13589 13594
16. T.R. Pak, W.C. Chung, T.D. Lund, L.R. Hinds, C.M. Clay, and R.J. Handa The androgen metabolite, 5alpha-androstane-3beta, 17beta-diol, is a potent modulator of estrogen receptor-beta1-mediated gene transcription in neuronal cells Endocrinology 146 2005 147 155
17. R.J. Handa, T.R. Pak, A.E. Kudwa, T.D. Lund, and L. Hinds An alternate pathway for androgen regulation of brain function: activation of estrogen receptor beta by the metabolite of dihydrotestosterone, 5alpha-androstane-3beta, 17beta-diol Horm Behav 53 2008 741 752
18. A. Wahlgren, K. Svechnikov, M.L. Strand, K. Jahnukainen, M. Parvinen, and J.A. Gustafsson Estrogen receptor beta selective ligand 5alpha-Androstane- 3beta, 17beta-diol stimulates spermatogonial deoxyribonucleic acid synthesis in rat seminiferous epithelium in vitro Endocrinology 149 2008 2917 2922
19. P. Mak, I. Leav, B. Pursell, D. Bae, X. Yang, and C.A. Taglienti ERbeta impedes prostate cancer EMT by destabilizing HIF-1alpha and inhibiting VEGF-mediated snail nuclear localization: implications for Gleason grading Cancer Cell 17 2010 319 332
20. A. Stahlberg, P. Aman, B. Ridell, P. Mostad, and M. Kubista Quantitative real-time PCR method for detection of B-lymphocyte monoclonality by comparison of kappa and lambda immunoglobulin light chain expression Clin Chem 49 2003 51 59
21. K.J. Livak, and T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method Methods 25 2001 402 408 [San Diego, Calif.]
22. M. Warner, and J.A. Gustafsson The role of estrogen receptor beta (ERbeta) in malignant diseases-a new potential target for antiproliferative drugs in prevention and treatment of cancer Biochem Biophys Res Commun 396 2010 63 66
23. C. Lattrich, J. Lubig, A. Springwald, R. Goerse, O. Ortmann, and O. Treeck Additive effects of trastuzumab and genistein on human breast cancer cells Anticancer Drugs 22 2011 253 261
24. A.M. Abukhdeir, B.G. Blair, K. Brenner, B. Karakas, H. Konishi, and J. Lim Physiologic estrogen receptor alpha signaling in non-tumorigenic human mammary epithelial cells Breast Cancer Res Treat 99 2006 23 33
25. G. Viale, A. Giobbie-Hurder, M.M. Regan, A.S. Coates, M.G. Mastropasqua, and P. Dell'Orto Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole J Clin Oncol: Offi J Am Soc Clin Oncol 26 2008 5569 5575
26. J.H. van Dierendonck, R. Keijzer, C.J. van de Velde, and C.J. Cornelisse Nuclear distribution of the Ki-67 antigen during the cell cycle: comparison with growth fraction in human breast cancer cells Cancer Res 49 1989 2999 3006
27. H.P. Li, J.F. Ji, K.Y. Hou, Y.T. Lei, H.M. Zhao, and J. Wang Prediction of recurrence risk in early breast cancer using human epidermal growth factor 2 and cyclin A2 Chin Med J 123 2010 431 437
28. K. Aaltonen, R.M. Amini, P. Heikkila, K. Aittomaki, A. Tamminen, and H. Nevanlinna High cyclin B1 expression is associated with poor survival in breast cancer Br J Cancer 100 2009 1055 1060
29. K. Lundgren, M. Brown, S. Pineda, J. Cuzick, J. Salter, and L. Zabaglo Effects of cyclin D1 gene amplification and protein expression on time to recurrence in postmenopausal breast cancer patients treated with anastrozole or tamoxifen: a TransATAC study Breast Cancer Res: BCR 14 2012 R57
30. A.R. Thorner, K.A. Hoadley, J.S. Parker, S. Winkel, R.C. Millikan, and C.M. Perou In vitro and in vivo analysis of B-Myb in basal-like breast cancer Oncogene 28 2009 742 751
31. A. Sala, and R. Watson B-Myb protein in cellular proliferation, transcription control, and cancer: latest developments J Cell Physiol 179 1999 245 250
32. S. Paruthiyil, A. Cvoro, X. Zhao, Z. Wu, Y. Sui, and R.E. Staub Drug and cell type-specific regulation of genes with different classes of estrogen receptor beta-selective agonists PLoS ONE 4 2009 e6271